Beyond weight loss, early exploratory data suggest potential benefits including: Reductions in HbA1c (a marker of blood sugar control) in people with type 2 diabetes Improvements in lipid profiles (cholesterol and triglycerides) Reductions in liver fat, which may be relevant for metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), though these findings are preliminary Possible cardiovascular benefits
J Endocrinol 2023;256
Published comparisons show: Minimal cortisol impact: Unlike GHRP-6, Ipamorelin does not significantly elevate cortisol in research models Minimal prolactin impact: GHRP-2 elevates prolactin
Most clients begin to feel more hydrated, refreshed, and energized within hours of treatment, with recovery benefits continuing over the next 2448 hours
This action helps the body lower blood sugar levels without causing hypoglycemia
These cases underscore the importance of careful monitoring and open communication between patients and clinicians regarding the use of complementary therapies